If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paola Matteucci is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles
Drug Therapy Medicine & Life Sciences
Stem Cells Medicine & Life Sciences
Salvage Therapy Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
Blood Cells Medicine & Life Sciences
Dendritic Cells Medicine & Life Sciences
Cytarabine Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 3300 Citations
  • 18 h-Index
  • 34 Article
  • 1 Letter

Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma

Dodero, A., Guidetti, A., Tucci, A., Barretta, F., Novo, M., Devizzi, L., Re, A., Passi, A., Pellegrinelli, A., Pruneri, G., Miceli, R., Testi, A., Pennisi, M., Di Chio, M. C., Matteucci, P., Carniti, C., Facchetti, F., Rossi, G. & Corradini, P., Apr 1 2019, In : Leukemia. 33, 4, p. 1047-1051 5 p.

Research output: Contribution to journalLetter

Open Access

Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi

Merli, F., Cavallo, F., Salvi, F., Tucci, A., Musuraca, G., Nassi, L., Merli, M., Tani, M., Gini, G., Ferrari, A., Molinari, A. L., Liberati, A. M., Conconi, A., Matteucci, P., Bari, A., Scalone, R., Ferrero, S., Zanni, M., Mammi, C. & Luminari, S., Jan 1 2019, In : Journal of Geriatric Oncology.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Confidence Intervals
Geriatric Assessment
Safety
obinutuzumab
1 Citation (Scopus)

Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO)

on behalf of NICSO (Network Italiano per le Cure di Supporto in Oncologia), Jan 1 2018, (Accepted/In press) In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Italy
Fatigue
Cross-Sectional Studies
Neoplasms
Therapeutics
14 Citations (Scopus)

Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study

Ruella, M., Filippi, A. R., Bruna, R., Di Russo, A., Magni, M., Caracciolo, D., Passera, R., Matteucci, P., Di Nicola, M., Corradini, P., Parvis, G., Gini, G., Olivieri, A., Ladetto, M., Ricardi, U., Tarella, C. & Devizzi, L., Mar 15 2016, In : International Journal of Radiation Oncology Biology Physics. 94, 4, p. 783-791 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
progressions
Multicenter Studies
Disease-Free Survival
radiation therapy

Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study

Ruella, M., Filippi, A. R., Bruna, R., Di Russo, A., Magni, M., Caracciolo, D., Passera, R., Matteucci, P., Di Nicola, M., Corradini, P., Parvis, G., Gini, G., Olivieri, A., Ladetto, M., Ricardi, U., Tarella, C. & Devizzi, L., 2016, In : International Journal of Radiation Oncology Biology Physics. 94, 4, p. 783-791 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
progressions
Multicenter Studies
Disease-Free Survival
radiation therapy